Literature DB >> 11970866

Phosphorylation of CREB Ser142 regulates light-induced phase shifts of the circadian clock.

Daniel Gau1, Thomas Lemberger, Charlotte von Gall, Oliver Kretz, Nguyet Le Minh, Peter Gass, Wolfgang Schmid, Ueli Schibler, Horst W Korf, Günther Schütz.   

Abstract

Biological rhythms are driven in mammals by a central circadian clock located in the suprachiasmatic nucleus (SCN). Light-induced phase shifting of this clock is correlated with phosphorylation of CREB at Ser133 in the SCN. Here, we characterize phosphorylation of CREB at Ser142 and describe its contribution to the entrainment of the clock. In the SCN, light and glutamate strongly induce CREB Ser142 phosphorylation. To determine the physiological relevance of phosphorylation at Ser142, we generated a mouse mutant, CREB(S142A), lacking this phosphorylation site. Light-induced phase shifts of locomotion and expression of c-Fos and mPer1 in the SCN are significantly attenuated in CREB(S142A) mutants. Our findings provide genetic evidence that CREB Ser142 phosphorylation is involved in the entrainment of the mammalian clock and reveal a novel phosphorylation-dependent regulation of CREB activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11970866     DOI: 10.1016/s0896-6273(02)00656-6

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  68 in total

1.  Phase resetting light pulses induce Per1 and persistent spike activity in a subpopulation of biological clock neurons.

Authors:  Sandra J Kuhlman; Rae Silver; Joseph Le Sauter; Abel Bult-Ito; Douglas G McMahon
Journal:  J Neurosci       Date:  2003-02-15       Impact factor: 6.167

2.  Circadian regulation of nocturnin transcription by phosphorylated CREB in Xenopus retinal photoreceptor cells.

Authors:  Xiaorong Liu; Carla B Green
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

3.  The immunosuppressive drugs cyclosporin A and tacrolimus inhibit membrane depolarization-induced CREB transcriptional activity at the coactivator level.

Authors:  Elke Oetjen; Kai-Martin Thoms; Yvonne Laufer; Daniela Pape; Roland Blume; Pingfeng Li; Willhart Knepel
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

Review 4.  CREB: a multifaceted regulator of neuronal plasticity and protection.

Authors:  Kensuke Sakamoto; Kate Karelina; Karl Obrietan
Journal:  J Neurochem       Date:  2010-12-02       Impact factor: 5.372

Review 5.  Signaling mechanisms linking neuronal activity to gene expression and plasticity of the nervous system.

Authors:  Steven W Flavell; Michael E Greenberg
Journal:  Annu Rev Neurosci       Date:  2008       Impact factor: 12.449

Review 6.  Physiological responses of the circadian clock to acute light exposure at night.

Authors:  Michael C Antle; Victoria M Smith; Roxanne Sterniczuk; Glenn R Yamakawa; Brooke D Rakai
Journal:  Rev Endocr Metab Disord       Date:  2009-12       Impact factor: 6.514

Review 7.  Mechanisms of specificity in neuronal activity-regulated gene transcription.

Authors:  Michelle R Lyons; Anne E West
Journal:  Prog Neurobiol       Date:  2011-05-18       Impact factor: 11.685

Review 8.  The circadian timing system: a recent addition in the physiological mechanisms underlying pathological and aging processes.

Authors:  Elvira Arellanes-Licea; Ivette Caldelas; Dalia De Ita-Pérez; Mauricio Díaz-Muñoz
Journal:  Aging Dis       Date:  2014-01-09       Impact factor: 6.745

9.  Increasing CRTC1 function in the dentate gyrus during memory formation or reactivation increases memory strength without compromising memory quality.

Authors:  Melanie J Sekeres; Valentina Mercaldo; Blake Richards; Derya Sargin; Vivek Mahadevan; Melanie A Woodin; Paul W Frankland; Sheena A Josselyn
Journal:  J Neurosci       Date:  2012-12-05       Impact factor: 6.167

10.  Role for the NR2B subunit of the N-methyl-D-aspartate receptor in mediating light input to the circadian system.

Authors:  L M Wang; A Schroeder; D Loh; D Smith; K Lin; J H Han; S Michel; D L Hummer; J C Ehlen; H E Albers; C S Colwell
Journal:  Eur J Neurosci       Date:  2008-04       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.